Loading...
Johnson & Johnson
JNJ.DE•XETRA
HealthcareDrug Manufacturers - General
€135.84
€1.54(1.15%)
Johnson & Johnson (JNJ.DE) Financial Performance & Statements
Review Johnson & Johnson’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
4.30%
↑ 4.30%
Operating Income Growth
-5.38%
↓ 5.38%
Net Income Growth
-59.99%
↓ 59.99%
Operating Cash Flow Growth
6.47%
↑ 6.47%
Operating Margin
24.75%
↑ 24.75%
Gross Margin
68.30%
↑ 68.30%
Net Profit Margin
24.41%
↑ 24.41%
ROE
29.95%
↑ 29.95%
ROIC
16.17%
↑ 16.17%
Johnson & Johnson (JNJ.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Johnson & Johnson stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $22.52B | $22.47B | $22.45B | $21.38B |
| Cost of Revenue | $7.13B | $6.96B | $6.87B | $6.51B |
| Gross Profit | $15.39B | $15.51B | $15.58B | $14.87B |
| Gross Profit Ratio | $0.68 | $0.69 | $0.69 | $0.70 |
| R&D Expenses | $5.30B | $4.95B | $3.44B | $3.54B |
| SG&A Expenses | $6.25B | $5.28B | $5.48B | $5.06B |
| Operating Expenses | $11.55B | $10.23B | $8.92B | $8.60B |
| Total Costs & Expenses | $18.68B | $17.19B | $15.79B | $15.11B |
| Interest Income | $281.00M | $292.00M | $395.00M | $364.00M |
| Interest Expense | $137.00M | $193.00M | $270.00M | $155.00M |
| Depreciation & Amortization | $1.90B | $1.85B | $1.78B | $1.81B |
| EBITDA | $5.92B | $5.38B | $7.80B | $5.68B |
| EBITDA Ratio | $0.26 | $0.24 | $0.35 | $0.27 |
| Operating Income | $3.84B | $5.28B | $6.66B | $6.27B |
| Operating Income Ratio | $0.17 | $0.23 | $0.30 | $0.29 |
| Other Income/Expenses (Net) | $46.00M | -$1.94B | -$909.00M | -$2.56B |
| Income Before Tax | $3.89B | $3.34B | $5.75B | $3.71B |
| Income Before Tax Ratio | $0.17 | $0.15 | $0.26 | $0.17 |
| Income Tax Expense | $456.00M | $644.00M | $1.06B | $459.00M |
| Net Income | $3.43B | $2.69B | $4.69B | $3.25B |
| Net Income Ratio | $0.15 | $0.12 | $0.21 | $0.15 |
| EPS | $1.43 | $1.12 | $1.95 | $2.20 |
| Diluted EPS | $1.41 | $1.11 | $1.93 | $2.20 |
| Weighted Avg Shares Outstanding | $2.41B | $2.41B | $2.41B | $2.41B |
| Weighted Avg Shares Outstanding (Diluted) | $2.43B | $2.43B | $2.42B | $2.43B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan